-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Alvotech And Teva Announce Acceptance Of U.S. Biologics License Application For Avt04

Reuters · 01/06/2023 04:02
BRIEF-Alvotech And Teva Announce Acceptance Of U.S. Biologics License Application For Avt04

- Alvotech Sa ALVO.O:

  • ALVOTECH AND TEVA ANNOUNCE ACCEPTANCE OF U.S. BIOLOGICS LICENSE APPLICATION FOR AVT04, A PROPOSED BIOSIMILAR TO STELARA® (USTEKINUMAB)

  • U.S. FOOD AND DRUG ADMINISTRATION'S (FDA) REGULATORY REVIEW IS ANTICIPATED TO BE COMPLETED IN SECOND HALF OF 2023

Source text for Eikon: ID:

Further company coverage: ALVO.O


((reuters.briefs@thomsonreuters.com;))